Pain Management in Outpatient Urologic Procedures
- Registration Number
- NCT03393364
- Lead Sponsor
- University Hospitals Cleveland Medical Center
- Brief Summary
Goal of this study is to evaluate how pain is controlled after outpatient urologic surgeries. Patients will receive either opioid pain medication or non-opioid medication for pain control. A survey will be conducted at the post-operative appointment to evaluate for pain control.
- Detailed Description
Patients will be approached in the pre-operative area prior to their outpatient urologic surgery. Informed Consent will be obtained at that time. Patients will be instructed that they will receive a prescription for either opioid pain medication or non-opioid medication for after surgery. The opioid medication includes oxycodone, while the non-opioid includes ketoralac, a non-steroidal anti-inflammatory medication. Subjects will be assigned randomly to either medication. Standard of care after outpatient urologic surgery is either oxycodone or ketoralac, however there is no previous research on whether one is superior than the other. These drugs were chosen because they are the most commonly used medications after outpatient urologic surgery. The study team and patients will not be blinded to the treatment.
They will also receive instructions for non-opioid pain management. If the patients require additional pain medication after surgery, they are instructed to call the provider's office for further evaluation and treatment. The patient's physician will prescribe further medication if warranted. The post-operative appointment is scheduled 2-3 weeks after surgery. At the post-operative appointment, patients will then be given a four question paper survey inquiring how well their pain was managed, how many pills were taken, if any additional non-opioid medications were taken for pain, and how the extra pills were disposed. Other PHI that will be collected includes patient's age, gender, past medical history, past surgical history, renal function, prior medications, and current surgery.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
- outpatient urologic surgery
- age 18 and over
- renal dysfunction
- non-English speaking
- employees of organization
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Opioid arm Oxycodone Patients receive opioid medication, oxycodone, after outpatient urologic surgery. Non-opioid arm Ketorolac Patients receive a non-opioid medication, ketorolac, after outpatient urologic surgery.
- Primary Outcome Measures
Name Time Method Pain control within 6 weeks of surgery Survey evaluating how well pain was controlled
- Secondary Outcome Measures
Name Time Method Number of pills used within 6 weeks of surgery Survey evaluating number of pills used
Trial Locations
- Locations (1)
University Hospitals
🇺🇸Cleveland, Ohio, United States